General Surgery·Edinburg, TX

Doctors Hospital at Renaissance, Ltd.

Signal lift18%51%+33 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
233–263
p10 – p90
Sample N
852
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.5%
4 of 42 applicants
01Cohort funnelthis cycle
N = 852
Applied
852
100.0%
Invited
42
4.9%
Class size
4
0.5%
J-1 visaCategorical
Your fitDoctors Hospital at Renaissance, Ltd. Program

Create a free profile to see your personalized fit

Get started
Contact
JA
Program Director
Jose L Almeda, MD, BS
Email director
GV
Program Coordinator
Grecia Vega, MD
Email coordinator
Training sites2 hospitals
  • 1
    Doctors Hospital at Renaissance Ltd
    Edinburg, TX
    Primary
  • 2
    Driscoll Children's Specialty Center-McAllen
    Mcallen, TX
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK233263
180205230255280

Level 2 CE data not available

Interview rates
US MD
15%
US DO
6%
US IMG
2%
Non-US IMG
2%
Applicant origin
In-state
46%
Out-of-state
2%
Interview prepGeneral Surgery
specialtyWhat drew you to surgery over medical specialties?★ common
specialtyAre you considering a fellowship after residency?★ common
clinicalDescribe your most challenging case in the OR.★ common
behavioralHow do you handle complications and bad outcomes?
clinicalWhat's your case log like?
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesGeneral Surgery · 25-26
Save this program

Add Doctors Hospital at Renaissance, Ltd. to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for General Surgery.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.